Display Settings:

Format

Send to:

Choose Destination
    J Cell Biol. 2005 Jun 6;169(5):789-99. Epub 2005 May 31.

    Class II phosphoinositide 3-kinase defines a novel signaling pathway in cell migration.

    Source

    Department of Medicine, The Sackler Institute, University College London, London WC1E 6JJ, England, UK.

    Abstract

    The lipid products of phosphoinositide 3-kinase (PI3K) are involved in many cellular responses such as proliferation, migration, and survival. Disregulation of PI3K-activated pathways is implicated in different diseases including cancer and diabetes. Among the three classes of PI3Ks, class I is the best characterized, whereas class II has received increasing attention only recently and the precise role of these isoforms is unclear. Similarly, the role of phosphatidylinositol-3-phosphate (PtdIns-3-P) as an intracellular second messenger is only just beginning to be appreciated. Here, we show that lysophosphatidic acid (LPA) stimulates the production of PtdIns-3-P through activation of a class II PI3K (PI3K-C2beta). Both PtdIns-3-P and PI3K-C2beta are involved in LPA-mediated cell migration. This study is the first identification of PtdIns-3-P and PI3K-C2beta as downstream effectors in LPA signaling and demonstration of an intracellular role for a class II PI3K. Defining this novel PI3K-C2beta-PtdIns-3-P signaling pathway may help clarify the process of cell migration and may shed new light on PI3K-mediated intracellular events.

    PMID:
    15928202
    [PubMed - indexed for MEDLINE]
    PMCID:
    PMC2171608
    Free PMC Article

    Images from this publication.See all images (9) Free text

    Figure 1.
    Figure 3.
    Figure 5.
    Figure 7.
    Figure 9.
    Figure 2.
    Figure 4.
    Figure 6.
    Figure 8.

      Supplemental Content

      Icon for HighWire Press Icon for PubMed Central

      Save items

      loading

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk